PD-1 inhibitor induces myocarditis by reducing regulatory T cells, activating inflammatory responses, promoting myocardial apoptosis and autophagy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1 inhibitor induces myocarditis by reducing regulatory T cells, activating inflammatory responses, promoting myocardial apoptosis and autophagy

Published:2022-09 Issue: Volume:157 Page:155932
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Liu Ying-xian,Song Yan-jun,Liu Xiao-hang,Xu Si-chi,Kong Chang,Chen Lian-feng,Qian Hao,Wu Wei

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference35 articles.

1. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4;Waterhouse;Science,1995

2. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance;Nishimura;Trends Immunol.,2001

3. Autoimmune Inflammatory Myopathy after Treatment with Ipilimumab;Hunter;Can. J. Neurol. Sci.,2009

4. Fulminant Myocarditis with Combination Immune Checkpoint Blockade;Johnson;N. Engl. J. Med.,2016

5. Drug-Associated Dermatomyositis Following Ipilimumab Therapy A Novel Immune-Mediated Adverse Event Associated With Cytotoxic T-Lymphocyte Antigen 4 Blockade;Sheik Ali;Jama Dermatology,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review;Cardiovascular Toxicology;2024-09-10

2. Immunotherapy Study on Non-small-Cell Lung Cancer (NSCLC) Combined with Cytotoxic T Cells and miRNA34a;Molecular Pharmaceutics;2024-01-31

3. Characteristics of splenic PD-1+ γδT cells in Plasmodium yoelii nigeriensis infection;Immunologic Research;2024-01-24

4. Identification of shared mechanisms and targets between immune checkpoint inhibitor-associated myocarditis and autoimmune myocarditis;European Journal of Inflammation;2024-01

5. Sex differences in regulatory T cells during autoimmune disease;Regulatory T Cells and Autoimmune Diseases;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3